🔗 Share this article Users Stopping Weight-Loss Medications Regain Pounds Far More Rapidly Than Those on Conventional Diets Weight management often requires ongoing approaches. Fresh analysis suggests that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens. Research printed in a leading medical journal points out that while obese individuals frequently drop a large proportion of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month once they quit. "Individuals buying such medications must be informed of the danger of rapid weight regain when the treatment ends," stated lead investigator Dr. Susan Jebb. Such speed of recovery means a reversion to pre-treatment weight in about a year and a half. Comparing Approaches The research, which looked at dozens of trials involving thousands of participants, contrasted the effects of these new drugs with other pills. The team emphasize that individuals who shed pounds through lifestyle changes alone generally see a slower creep back—around 0.1 kg a month—once they finish. Explaining the Quick Rebound Doctors suggest the mode of action of the jabs is key to understanding the accelerated weight return. The injections imitate a body's own chemical called glucagon-like peptide-1, which controls hunger. "Sustained high doses of GLP-1 concentrations far above than normal might result in the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert. "Stopping of this medication leads to appetite is no longer kept in check, making binge eating much more probable." A Lifelong Disease? Health authorities advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes. Professionals argue that, due to the high risk of weight regain, the treatment is often ongoing. This view is reinforced by pharmaceutical companies, who note that the results "underscore the chronic character of excess weight," similar to managing conditions like high blood pressure. User Experiences Individuals who have stopped the jabs explain a intense return of cravings. "I experienced a switch activating and I was suddenly extremely hungry," described an individual. The struggle is worsened if individuals have not developed lasting lifestyle or habit modifications during therapy. Significant Interest Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow. Adoption is greater among women compared to males. The 40s and 50s demographic shows the highest usage rates. Many access the medications through private healthcare rather than the NHS. In conclusion, experts caution that while the jabs are powerful tools for shedding pounds, they are not a magic cure and maintained weight loss relies on combined behavioural support.
Weight management often requires ongoing approaches. Fresh analysis suggests that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens. Research printed in a leading medical journal points out that while obese individuals frequently drop a large proportion of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month once they quit. "Individuals buying such medications must be informed of the danger of rapid weight regain when the treatment ends," stated lead investigator Dr. Susan Jebb. Such speed of recovery means a reversion to pre-treatment weight in about a year and a half. Comparing Approaches The research, which looked at dozens of trials involving thousands of participants, contrasted the effects of these new drugs with other pills. The team emphasize that individuals who shed pounds through lifestyle changes alone generally see a slower creep back—around 0.1 kg a month—once they finish. Explaining the Quick Rebound Doctors suggest the mode of action of the jabs is key to understanding the accelerated weight return. The injections imitate a body's own chemical called glucagon-like peptide-1, which controls hunger. "Sustained high doses of GLP-1 concentrations far above than normal might result in the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert. "Stopping of this medication leads to appetite is no longer kept in check, making binge eating much more probable." A Lifelong Disease? Health authorities advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes. Professionals argue that, due to the high risk of weight regain, the treatment is often ongoing. This view is reinforced by pharmaceutical companies, who note that the results "underscore the chronic character of excess weight," similar to managing conditions like high blood pressure. User Experiences Individuals who have stopped the jabs explain a intense return of cravings. "I experienced a switch activating and I was suddenly extremely hungry," described an individual. The struggle is worsened if individuals have not developed lasting lifestyle or habit modifications during therapy. Significant Interest Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow. Adoption is greater among women compared to males. The 40s and 50s demographic shows the highest usage rates. Many access the medications through private healthcare rather than the NHS. In conclusion, experts caution that while the jabs are powerful tools for shedding pounds, they are not a magic cure and maintained weight loss relies on combined behavioural support.